A Reproductive and Developmental Toxicity Study in CD Rats of LY275585,[Lys(B28),Pro(B29)]-Human Insulin

Abstract

LY275585, [Lys(B28),Pro(B29)]-human insulin, was administered daily by subcutaneous injection at doses of 0, 1, 5, or 20 U/kg. Male rats were treated with LY275585 beginning 2 weeks prior to cohabitation and throughout the mating period. Females assigned to the teratology component of the study were treated for 2 weeks prior to cohabitation with the males and through gestation day (GD) 19. These dams were killed on GD 20 and uterine and fetal examinations were performed. Female rats assigned to the delivery component were treated for 2 weeks prior to cohabitation through postpartum day (PD) 20. Dams were allowed to deliver and maintain their progeny through a 21-day lactation period. After weaning, 1 pup/sex/litter was assigned to the F₁ generation, and these animals received no treatment. Survival, growth, behavior, and reproductive performance were evaluated, and reproductive organs were collected for histological evaluation. Treatment of F₀ male and female rats with LY275585 resulted in isolated incidences of severe hypoglycemia at 5 and 20 U/kg/day and some modest changes in food consumption and body weight measures at all treatment levels. These changes were anticipated and attributed to the pharmacology of this compound. Mating and fertility of the F₀ animals were unaffected by treatment. While slight decreases in fetal body weights and increased fetal runts/litter were observed in the 20-U/kg/day group, PD 1 progeny weights were not affected in the delivery component, and there was no indication of teratogenicity in this study. There were no remarkable treatment-related effects on offspring growth patterns, survival, or reproductive performance, but the F₁ animals from the 20-U/kg/day treatment-derived group were more reactive than controls in the startle habituation test. Thus, F₀ parental toxicity, related to the hypoglycemic action of LY275585, was found at all doses. A dose of 5 U/kg/day was considered a no-adverse-effect level for developmental toxicity. There were no remarkable effects of LY275585 treatment on F₀ or F₁ generation reproductive performance at 20 U/kg/day, the highest dose tested in this study.

Keywords

LY275585 [Lys(B28),Pro(B29)]-Human insulin Toxicity study.

References

Adams J , Buelke-Sam J , Kimmel CA , et al. (1985) Collaborative behavioral teratology study: protocol design and testing procedures. Neurobehav Toxicol Teratol 7:669-73.

Anderson VL , McLean RA . (1974) Design of Experiments: a Realistic Approach. New York: Dekker, 16-22.

Antonello JMM , Clark RL , Heyse JF . (1993) Application of the Tukey trend test procedure to assess developmental and reproductive toxicity. I. Measurement data. Fundam Appl Toxicol 21:52-8.

Barrow MV , Taylor WJ . (1969). A rapid method for detecting malformations in rat fetuses. J Morphol 127:291-305.

Brems DN , Alter LA , Beckage MJ , et al. (1992a) Altering the association properties of insulin by amino acid replacement. Protein Eng 5:527-33.

Brems DN , Bryant C , Chance RE , et al. (1992b) Improved insulin stability through amino acid substitution. Protein Eng 5:519-25.

Brinsmade AF , Buchner F , Rubsaamen H . (1956). Missbildungen am Kaninchenembryo durch Insulin-injektion beim Muttertier. Naturwissenschaften 43:259.

Buelke-Sam J , Byrd RA , Johnson JA , Tizzano J , Owen NV . (1991a) Developmental toxicity of the dopamine agonist pergolide mesylate in CD-I mice I: gestational exposure. Neurotoxicol Teratol 13:283-95.

Buelke-Sam J , Byrd RA , Nelson CJ . (1983) Blood flow during pregnancy in the rat: III. Alterations following Mirex treatment. Teratology 27:401-10.

10.

Buelke-Sam J , Cohen IR , Tizzano J , Owen NV . (1991b) Developmental toxicity of the dopamine agonist pergolide mesylate in CD-I mice II: perinatal and postnatal exposure. Neurotoxicol Teratol 13:297-306.

11.

Buelke-Sam J , Hagopian GS , Probst KS , Fisher LF , Matsuda K . (1989a) A developmental toxicology study of nizatidine administered orally to CD rats during gestation [Japanese]. Jpn Pharmacol Ther 17:199-222.

12.

Buelke-Sam J , Holson JF , Nelson CJ . (1982a) Blood flow during pregnancy in the rat: II. Dynamics of litter variability in uterine flow. Teratology 26:279-88.

13.

Buelke-Sam J , Nelson CJ , Byrd RA , Holson JF . (1982b) Blood flow during pregnancy in the rat: I. Flow patterns to maternal organs. Teratology 26:269-77.

14.

Buelke-Sam J , Tizzano J , Probst KS , Fisher LF , Matsuda K . (1989b) Effects of nizatidine administered orally to CD rats during the perinatal and postnatal periods [Japanese]. Jpn Pharmacol Ther 17:223-41.

15.

Byrd RA , Kimmel CA , Morris MD , Holson JF , Young JF . (1981) Altered pattern of prenatal toxicity in rats due to different treatment schedules with Mirex. Toxicol Appl Pharmacol 60:213-9.

16.

Chomette G . (1955) Entwicklungstorungen nach Insulinschock beim trachtiger Kaninchen. Beitr Path Anat 115:439-51.

17.

Collins TFX , Welsh JJ , Black TN , Collins EV . (1981) A study of the teratogenic potential of caffeine given by oral intubation to rats. Regul Toxicol Pharmacol 1:355-78.

18.

Conover WJ , Iman RL . (1981) Rank transformations as a bridge between parametric and nonparametric statistics. Am Stat 35:124-33.

19.

DiMarchi RD , Mayer JP , Fan L , et al. (1992). Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor I. In: Smith JA , River JE , eds. Peptides, chemistry and biology. Leiden: ESCOM, 26-8.

20.

Dunn OJ , Clark VA . (1974a) Single factor analysis of variance-other designs. In: Applied Statistics: Analysis of Variance and Regression. New York: Wiley, 90-9.

21.

Dunn OJ , Clark VA . (1974b) Analysis of covariance. In: Applied Statistics: Analysis of Variance and Regression. New York: Wiley, 307-35.

22.

Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 20:482-91.

23.

Food and Drug Administration. (1978) Good laboratory practice for nonclinical laboratory studies. 21 CRF pt 58, Good Laboratory Practice Regulations; final rule.

24.

Freeman MF , Tukey JW . (1950) Transformations related to the angular and the square root. Ann Math Stat 21:607-11.

25.

Gamst-Andersen H , Hjortkjaer RK , Lorenzen FH , Ashby R . (1983). Preclinical studies on human insulin. I. Acute and subacute toxicity studies. Acta Pharmacol Toxicol 52:261-7.

26.

Gaylor DW . (1978) Methods and concepts of biometrics applied to teratology. In: Wilson JG , Fraser FC , eds. Handbook of Teratology, vol 4. New York: Plenum Press, 429-44.

27.

Haseman JK , Hogan MD . (1975) Selection of the experimental unit in teratology studies. Teratology 12:165-72.

28.

Khera KS . (1981) Common fetal aberrations and their teratologic significance: a review. Fundam Appl Toxicol 1:13-8.

29.

Leuschner F , Czok G . (1973) Reversibilitat Pranataler Coffeinschaden bei Ratten [Reversibility of prenatal injuries induced by caffeine in rats]. Colloq Int Chim Cafes [CR] 5:388-91.

30.

Miller JR . (1962) A strain difference in response to the teratogenic effect of maternal fasting in the house mouse. Can J Genet Cytol 4:69-78.

31.

Molsted-Pedersen L . (1980) Pregnancy and diabetes: a survey. Acta Endocrinol 94(suppl 238): 13-9.

32.

Palmer AK . (1972) Sporadic malformations in laboratory animals and their influence on drug testing. Adv Exp Med Biol 27:45-60.

33.

Palmer AK . (1977) Incidence of sporadic malformations, anomalies, and variations in random bred laboratory animals. In: Neubert D , Merker HJ , Kwasigroch TE , eds. Methods in Prenatal Toxicology. Stuttgart: Georg Thieme, 52-71.

34.

Palmer AK . (1978) The design of subprimate animal studies. In: Wilson JG , Fraser FC , eds. Handbook of Teratology, vol 4. New York: Plenum Press, 215-53.

35.

Piegorsch WW , Haseman JK . (1991) Statistical methods for analyzing developmental toxicity data. Teratog Carcinog Mutagen 11:115-33.

36.

Reiter LW . (1983) Chemical exposure and animal activity: utility of the figure-8 maze. In: Hayes AW , Schnell RC , Miyou TS , eds. Developments in the Science and Practice of Toxicology. New York: Elsevier Press, 73-84.

37.

Runner MN , Miller JR . (1956) Congenital deformity in the mouse as a consequence of fasting. Anal Rec 124:437-8.

38.

Salewski E . (1964) Farbemethoden zum makroskopischer Nachweis von Implantationsstellen am Uterus der Ratte [Staining method for a macroscopic test for implantation points in the uterus of the rat]. Naunyn Schmiedebergs Arch Pharmacol 247:367.

39.

SAS Institute, Inc. (1986) The TABLES procedure. In: SUGI supplemental user's guide, version 5. 3rd ed. Cary, NC: SAS Institute, 579-606.

40.

SAS Institute, Inc. (1990) SAS/STAT user's guide, version 6. 4th ed. Cary, NC: SAS Institute, 891-996.

41.

Schardein JL . (1993) Chemically Induced Birth Defects. 2nd ed. New York: Dekker, 416-25.

42.

Shaw WN , Su KSE . (1991) Biological aspects of a new human insulin analog: [Lys(B28),Pro(B29)]-human insulin. Diabetes 40(suppl 1):464A.

43.

Smithberg M , Runner MN . (1963) Teratogenic effects of hypoglycemic treatments in inbred strains of mice. Am J Anat 113:479-89.

44.

Smithberg M , Sanches HW , Runner MN . (1956) Congenital deformity in the mouse induced by insulin. Anat Rec 124:441.

45.

Sokal RR , Rohlf FJ . (1969) Assumptions of analysis of variance. In: Emmerson R , Kennedy D , Park R , eds. Biometry, the Principles and Practices of Statistics in Biological Research. San Francisco: Freeman, 369-77.

46.

Staples RE , Schnell VL . (1964) Refinements in rapid clearing technic in the KOH-Alizarin Red S method for fetal bone. Stain Technol 39:61-3.

47.

Steel RGD , Torrie JH . (1980) Some uses of chi-square. Homogeneity of variance. In: Principles and Procedures of Statistics: a Biometrical Approach. 2nd ed. New York: McGraw-Hill, 471-2.

48.

Tukey JW , Ciminera JL , Heyse JE . (1985) Testing the statistical certainty of a response to increasing doses of a drug. Biometrics 41:295-301.

49.

Weil CS . (1970) Selection of the valid number of sampling units and a consideration of their combination in toxicological studies involving reproduction, teratogenesis, or carcinogenesis. Food Cosmet Toxicol 8:177-82.

50.

Wilson JG . (1965) Methods for administering agents and detecting malformations in experimental animals. In: Wilson JG , Warkany J , eds. Teratology: Principles and Techniques. Chicago: University of Chicago Press, 262-77.

51.

Woodworth J, Howey D, Bowsher R, Santa P, Lutz S, Brady P. (1993) [Lys(B 28), Pro(B 29)] human insulin dose-ranging vs. Humulin R. Presented at the 53rd Annual Meeting of the American Diabetes Association, Las Vegas.